Exome Asset Management »

Monte Rosa Therapeutics shares owned by Exome Asset Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.0M 180k 16.45

More positions owned by Exome Asset Management

Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Enliven Therapeutics (ELVN)
Ionis Pharmaceuticals (IONS)
Spdr Series Trust State Street Spd Put Option (XBI)
Guardant Health (GH)
Cytokinetics Com New (CYTK)
Eli Lilly & Co. (LLY)
Alumis (ALMS)
Bridgebio Pharma (BBIO)
Vera Therapeutics Cl A (VERA)
Insmed Com Par $.01 (INSM)
Anthem (ELV)
Agios Pharmaceuticals (AGIO)
United Therapeutics Corporation (UTHR)

View all positions for Exome Asset Management

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
TCG Crossover Management
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vestal Point Capital
State Street Corporation
Braidwell
Versant Venture Management
Vanguard Capital Management
American Century Companies
Silverarc Capital Management
Aisling Capital Management
Geode Capital Management

View all funds holding Monte Rosa Therapeutics